Key result
New review summarizes current pharmacotherapy for diabetes in CKD.
Answers are grounded in this paper and cite their sources.
Offers concise guidance for diabetes pharmacotherapy in CKD; leaves open need for updated RCTs in advanced renal impairment.
International audience
No takes yet. Share an insight, caveat, or question.
Gundeti et al. (2026) studied this question. Pharmacotherapy for diabetes in chronic kidney disease is summarized in this basic overview for an international audience.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: